Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Obesity

Study Reveals Child's Weight Has Little Effect On Mood, Behavioural Disorders

According to a new study, childhood BMI is unlikely to have a significant impact on children's mood or behavioural disorders. Read on for details:

Dynamite News

Fast Food Consumption Linked To Liver Disease: Study

A study published in Clinical Gastroenterology and Hepatology by Keck Medicine at USC provides more motivation for people to minimise their fast-food consumption. Read on for details:

Dynamite News

Why food deprivation in childhood is linked to obesity

As energy prices rise and the cost of living goes up, it is estimated that there are 4 million children from poorer households who have limited or uncertain access to healthy food.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

New pediatric guidelines for treating obese children include surgery and meds

The American Academy of Pediatrics published guidelines for treating the 14.4 million U.S. children and teens afflicted by obesity on Monday.

Tribune News Service

Childhood obesity requires early, aggressive treatment, new guidelines say

Instead of "watchful waiting," the American Academy of Pediatrics now recommends intensive lifestyle and behavior therapy for young kids, and for older children, medication.

WEKU

Pediatricians say obese children in the US should be given weight loss drugs in controversial new ruling

‘There is research that shows that getting bariatric surgery sooner can reverse health issues like Type 2 diabetes’

The Independent UK

New guidance: Use drugs, surgery early for obesity in kids

New guidelines suggest children struggling with obesity should be evaluated and treated early and aggressively

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

2023 could be a banner year for prescription drugs

There's a large pipeline of promising yet expensive drugs that could get approved.

Axios

Losing weight doesn't resolve inflammation tied to weight gain, mouse study suggests

In a mouse study published Thursday in the journal Science, researchers found that inflammation lingered in mice that had been fed a high-fat diet after the rodents shed the ounces.

Inverse

IBD Stock Of The Day: How These Issues In 2023 Could Spark, Or Slam, Eli Lilly Stock

Eli Lilly is the IBD Stock Of The Day as the company explores new methods of treating Alzheimer's and obesity, driving LLY stock near highs.

Investors Business Daily

Researchers Identify Two Distinct Types Of Obesity

Offer a more nuanced understanding of obesity than current definitions and may one day inform more precise ways to diagnose and treat obesity and associated metabolic disorders. Read on for details:

Dynamite News

The Battles Brewing That Could Stoke Already Red-Hot Eli Lilly Stock

Investors are closely watching two Eli Lilly battles that will unfold in 2023 as LLY stock continues a fevered streak, tacking on new highs.

Investors Business Daily

Study Explains 'Eating just One Potato Chip Is Impossible' Gene

A gene called CREB-Regulated Transcription Coactivator 1 (CRTC1) is associated with obesity in humans. Read on for details:

Dynamite News

Health: Japanese Research Reveals What Triggers Our Brain To Indulge In Overeating

Despite knowing that high calories foods are detrimental to our health, overeating or binge-eating is a common tendency among many. What triggers this tendency in the brain? Read on for details:

Dynamite News

Get all your
news in one place.

100’s of premium titles.
One news app.

ABC News

Semaglutide is causing a social media frenzy. So what is it?

It is not a a viral meme, but a drug that is an injectable medication — originally designed to treat diabetes — that has left those who need it waiting until next year for resupply.

The Conversation

GPs don't give useful weight-loss advice – new study

The advice general practitioners give to patients with obesity in the UK was found to be “highly varied, superficial and often lacked an apparent evidence base”, according to a new study from the University of Oxford.

Investors Business Daily

The Bullish Call Eli Lilly Made For Its Next-Gen Obesity Drug, A Rival To Novo, Amgen

Eli Lilly said Tuesday it plans to advance its next-generation obesity treatment into final-phase testing, but LLY stock dipped on guidance.

Dynamite News

Study Suggests Obese Patients Get Ineffective Weight Loss Advice From Doctors

The investigation found that weight-loss advice from doctors to patients with obesity rarely included effective methods and mostly consisted of telling patients merely to eat less and be more physically active. Read on for details:

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

Study: If 20% of your diet is these foods, you’re at risk of faster cognitive decline

Numerous studies have linked the consumption of ultraprocessed foods with a greater risk of inflammatory bowel disease, cancer, obesity and early death.

The Independent UK

The Whale director Darren Aronofsky says fatphobia criticisms ‘make no sense’

‘Black Swan’ filmmaker claimed that ‘people with obesity are generally written as bad guys or as punchlines’

Investors Business Daily

How An Eli Lilly Decision Could Light Up The Red-Hot Obesity Landscape — Again

A key decision from Eli Lilly could alight the obesity treatment landscape again, an analyst said Friday as LLY stock lingers near a record.

The Conversation

Picky eater? Research shows it could be in your DNA

In the last 40 years obesity has been constantly rising. This has happened despite the popularity of all kind of diets ranging from low carb, paleo or even ice cream based.

The Guardian - UK

Sunak faces backlash over delay to junk food pre-watershed ads ban

Scrapping of adverts for foods high in fat, salt and sugar before 9pm will not now take effect until 2025

Investors Business Daily

Here's What We Know So Far About Amgen's Obesity Drug As It Trails Novo Nordisk, Eli Lilly

Amgen is years behind rivals in developing an obesity treatment, but the company says its experimental drug could prove superior.

ABC News

New research identifies some food products aimed at toddlers are failing WHO guidelines around sugar content

Out of more than 70 ready-made food products for toddlers, more than 75 per cent fail to meet the proposed guidelines for sugar set out by the World Health Organization (WHO), soon-to-be-published research for the Obesity Policy Coalition has found.

1 … 35 36 37 38

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

University of Minnesota

49 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.